{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.0","upperLimit":"6.1","value":"3.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"description":"Response duration in months","dispersionType":"80% Confidence Interval","groups":[{"description":"Gemcitabine given 3000 mg/m2 IV over 30 minutes and Docetaxel given 60mg/m2 IV over 60 minutes. The Docetaxel should be administered after the Gemcitabine.\n\ndocetaxel: Gemcitabine given 3000 mg/m2 IV over 30 minutes and Docetaxel given 60mg/m2 IV over 60 minutes. The Docetaxel should be administered after the Gemcitabine.\n\nGemcitabine: Gemcitabine given 3000 mg/m2 IV over 30 minutes and Docetaxel given 60mg/m2 IV over 60 minutes. The Docetaxel should be administered after the Gemcitabine.","id":"OG000","title":"Gemcitabine, Docetaxel"}],"paramType":"MEDIAN","populationDescription":"Only those patients that have a recorded CR or PR","reportingStatus":"POSTED","timeFrame":"Every 8 weeks","title":"Response Duration","type":"SECONDARY","unitOfMeasure":"months"}